Verdicts genuinely change. Free email alert the moment RYOAX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Biotechnology Fund · Rydex Series Funds
74 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 101% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 21.72% of portfolio weight is in non-compliant holdings, over the 5% threshold.
0.59% of that is conventional interest-bearing debt, identified from the fund's own filing rather than by screening an issuer. Sukuk are deliberately excluded from this test and are never counted here.
74 holdings, 56 matched (84% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
7.41% of this portfolio’s income is non-permissible — weighted across holdings, computed over 57% of portfolio weight (42 of 74 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
62.1% compliant 0.0% questionable 21.6% non-compliant 16.4% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| ABBV ABBVIE INC | COMPLIANT | 8.17% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| AMGN AMGEN INC | COMPLIANT | 5.05% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GILD GILEAD SCIENCES INC | COMPLIANT | 4.49% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 4.32% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| REGN REGENERON PHARMACEUTICALS INC | COMPLIANT | 2.93% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| REVOLUTION MEDICINES INC | UNSCREENED | 2.48% | no in-house ratios for this holding |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 2.36% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ONC BEONE MEDICINES LTD | COMPLIANT | 2.17% | AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7% |
| MRNA MODERNA INC | NON_COMPLIANT | 2.15% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| BIIB BIOGEN INC | COMPLIANT | 2.13% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| NTRA NATERA INC | COMPLIANT | 2.12% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| RPRX ROYALTY PHARMA PLC | NON_COMPLIANT | 2.01% | AAOIFI24.4% Usmani45.2% Dow Jones Islamic60.3% S&P Shariah67.3% MSCI Islamic45.2% MSCI Islamic M-Series67.3% FTSE Shariah45.2% |
| ILMN ILLUMINA INC | COMPLIANT | 1.94% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| INSMED INC | UNSCREENED | 1.79% | no in-house ratios for this holding |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 1.72% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| GH GUARDANT HEALTH INC | COMPLIANT | 1.72% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| ROIVANT SCIENCES LTD | UNSCREENED | 1.66% | no in-house ratios for this holding |
| INCY INCYTE CORP | COMPLIANT | 1.62% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| VTRS VIATRIS INC | NON_COMPLIANT | 1.55% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| NBIX NEUROCRINE BIOSCIENCES INC | COMPLIANT | 1.52% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| ARGX ARGENX SE | COMPLIANT | 1.48% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| JAZZ JAZZ PHARMACEUTICALS PLC | COMPLIANT | 1.42% | AAOIFI31.0% Usmani39.7% Dow Jones Islamic44.2% S&P Shariah48.5% MSCI Islamic39.7% MSCI Islamic M-Series48.5% FTSE Shariah39.3% |
| BBIO BRIDGEBIO PHARMA INC | COMPLIANT | 1.38% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 1.35% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| CYTK CYTOKINETICS INC | NON_COMPLIANT | 1.35% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| EXEL EXELIXIS INC | COMPLIANT | 1.33% | AAOIFI1.2% Usmani6.7% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic6.7% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| ALKS ALKERMES PLC | COMPLIANT | 1.31% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ARWR ARROWHEAD PHARMACEUTICALS INC | COMPLIANT | 1.25% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BMRN BIOMARIN PHARMACEUTICAL INC | NON_COMPLIANT | 1.24% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| AZN ASTRAZENECA PLC | COMPLIANT | 1.23% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| HALO HALOZYME THERAPEUTICS INC | COMPLIANT | 1.17% | AAOIFI17.2% Usmani83.3% Dow Jones Islamic27.4% S&P Shariah30.4% MSCI Islamic83.3% MSCI Islamic M-Series30.4% FTSE Shariah83.3% |
| 22UA.DE BIONTECH SE | NON_COMPLIANT | 1.16% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| CRSP CRISPR THERAPEUTICS AG | NON_COMPLIANT | 1.16% | AAOIFI15.5% Usmani29.6% Dow Jones Islamic17.0% S&P Shariah16.8% MSCI Islamic29.6% MSCI Islamic M-Series16.8% FTSE Shariah22.1% |
| VAXCYTE INC | UNSCREENED | 1.16% | no in-house ratios for this holding |
| TGTX TG THERAPEUTICS INC | COMPLIANT | 1.08% | AAOIFI8.8% Usmani46.0% Dow Jones Islamic13.7% S&P Shariah17.0% MSCI Islamic46.0% MSCI Islamic M-Series17.0% FTSE Shariah45.5% |
| MEDP MEDPACE HOLDINGS INC | COMPLIANT | 1.03% | AAOIFIpass Usmani— Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariah— |
| APOGEE THERAPEUTICS INC | UNSCREENED | 1.02% | no in-house ratios for this holding |
| COGENT BIOSCIENCES INC | UNSCREENED | 1.00% | no in-house ratios for this holding |
| TWST TWIST BIOSCIENCE CORP | COMPLIANT | 0.98% | AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| PTCT PTC THERAPEUTICS INC | NON_COMPLIANT | 0.98% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| SCHOLAR ROCK HOLDING CORP | UNSCREENED | 0.98% | no in-house ratios for this holding |
| NUVALENT INC | UNSCREENED | 0.98% | no in-house ratios for this holding |
| AXSM AXSOME THERAPEUTICS INC | COMPLIANT | 0.96% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| CG ONCOLOGY INC | UNSCREENED | 0.96% | no in-house ratios for this holding |
| KRYS KRYSTAL BIOTECH INC | NON_COMPLIANT | 0.93% | AAOIFI0.1% Usmani0.6% Dow Jones Islamic0.1% S&P Shariah0.2% MSCI Islamic0.6% MSCI Islamic M-Series0.2% FTSE Shariah0.0% |
| VIKING THERAPEUTICS INC | UNSCREENED | 0.90% | no in-house ratios for this holding |
| TVTX TRAVERE THERAPEUTICS INC | COMPLIANT | 0.90% | AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4% |
| PTGX PROTAGONIST THERAPEUTICS INC | NON_COMPLIANT | 0.89% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ASND ASCENDIS PHARMA A/S | COMPLIANT | 0.89% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VCYT VERACYTE INC | COMPLIANT | 0.88% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| LQDA LIQUIDIA CORP | COMPLIANT | 0.86% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 0.83% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| MDGL MADRIGAL PHARMACEUTICALS INC | COMPLIANT | 0.79% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| RARE ULTRAGENYX PHARMACEUTICAL INC | NON_COMPLIANT | 0.77% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| BEAM BEAM THERAPEUTICS INC | NON_COMPLIANT | 0.74% | AAOIFI8.2% Usmani17.8% Dow Jones Islamic10.4% S&P Shariah10.7% MSCI Islamic17.8% MSCI Islamic M-Series10.7% FTSE Shariah7.2% |
| IMMUNITYBIO INC | UNSCREENED | 0.74% | no in-house ratios for this holding |
| MIRM MIRUM PHARMACEUTICALS INC | COMPLIANT | 0.74% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| PRAXIS PRECISION MEDICINES INC | UNSCREENED | 0.72% | no in-house ratios for this holding |
| RYTM RHYTHM PHARMACEUTICALS INC | NON_COMPLIANT | 0.71% | AAOIFI1.6% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic25.1% MSCI Islamic M-Series2.5% FTSE Shariah24.3% |
| ACAD ACADIA PHARMACEUTICALS INC | COMPLIANT | 0.71% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| NTLA INTELLIA THERAPEUTICS INC | NON_COMPLIANT | 0.65% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | COMPLIANT | 0.63% | AAOIFI3.8% Usmani23.4% Dow Jones Islamic5.0% S&P Shariah6.5% MSCI Islamic23.4% MSCI Islamic M-Series6.5% FTSE Shariah22.3% |
| DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT | NON_COMPLIANT | 0.59% | no in-house ratios for this holding |
| RXRX RECURSION PHARMACEUTICALS INC | NON_COMPLIANT | 0.55% | AAOIFI3.4% Usmani5.5% Dow Jones Islamic7.3% S&P Shariah6.1% MSCI Islamic5.5% MSCI Islamic M-Series6.1% FTSE Shariah1.2% |
| SAREPTA THERAPEUTICS INC | UNSCREENED | 0.54% | no in-house ratios for this holding |
| SUMMIT THERAPEUTICS INC | UNSCREENED | 0.53% | no in-house ratios for this holding |
| LEGN LEGEND BIOTECH CORP | COMPLIANT | 0.50% | AAOIFI8.8% Usmani18.4% Dow Jones Islamic2.9% S&P Shariah2.3% MSCI Islamic18.4% MSCI Islamic M-Series2.3% FTSE Shariah18.4% |
| ADMA ADMA BIOLOGICS INC | COMPLIANT | 0.50% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahpass |
| CELCUITY INC | UNSCREENED | 0.45% | no in-house ratios for this holding |
| GRAL GRAIL INC | NON_COMPLIANT | 0.38% | AAOIFI2.5% Usmani3.2% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic3.2% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| J.P. MORGAN SECURITIES LLC | UNSCREENED | 0.30% | no in-house ratios for this holding |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | UNSCREENED | 0.30% | no in-house ratios for this holding |
| Akero Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| SNY SANOFI SA - CVR | COMPLIANT | 0.00% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
The published standards disagree about this fund by 35 points of portfolio weight — 43.3% of it passes AAOIFI, 7.9% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 43.3% ratios fail on 18.4% 39.1% not rated under AAOIFI
ratios pass on 11.2% ratios fail on 46.3% 43.4% not rated under Usmani
ratios pass on 39.4% ratios fail on 20.4% 41.0% not rated under Dow Jones Islamic
ratios pass on 39.4% ratios fail on 20.4% 41.0% not rated under S&P Shariah
ratios pass on 7.9% ratios fail on 55.5% 37.4% not rated under MSCI Islamic
ratios pass on 39.4% ratios fail on 20.4% 41.0% not rated under MSCI Islamic M-Series
ratios pass on 11.2% ratios fail on 46.3% 43.4% not rated under FTSE Shariah
55 of 74 listed holdings carry our own per-methodology verdicts (84% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 41 (56% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| MRNA MODERNA INC | 2.15% |
| RPRX ROYALTY PHARMA PLC | 2.01% |
| UTHR UNITED THERAPEUTICS CORP | 1.72% |
| VTRS VIATRIS INC | 1.55% |
| IONS IONIS PHARMACEUTICALS INC | 1.35% |
| CYTK CYTOKINETICS INC | 1.35% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 1.24% |
| 22UA.DE BIONTECH SE | 1.16% |
| CRSP CRISPR THERAPEUTICS AG | 1.16% |
| PTCT PTC THERAPEUTICS INC | 0.98% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Biotechnology Fund (RYOAX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| ABBVABBVIE INC | 8.17% | Compliant |
| AMGNAMGEN INC | 5.05% | Compliant |
| GILDGILEAD SCIENCES INC | 4.49% | Compliant |
| VRTXVERTEX PHARMACEUTICALS INC | 4.32% | Compliant |
| REGNREGENERON PHARMACEUTICALS INC | 2.93% | Compliant |
| REVOLUTION MEDICINES INCnot matched to a ticker | 2.48% | Not screened |
| ALNYALNYLAM PHARMACEUTICALS INC | 2.36% | Compliant |
| ONCBEONE MEDICINES LTD | 2.17% | Compliant |
| MRNAMODERNA INC | 2.15% | Non-compliant |
| BIIBBIOGEN INC | 2.13% | Compliant |
Top 10 of 74 holdings, 36.2% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for RYOAX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
ℹ️ no compliance scan has run for 2 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 47.80 | NEUTRAL |
| Stochastic %K (14) | 41.49 | NEUTRAL |
| CCI (20) | -50.60 | NEUTRAL |
| Williams %R (14) | -58.51 | NEUTRAL |
| MACD (12,26,9) | -0.16 | SELL |
| ROC (10) | -2.43 | SELL |
| Momentum (10) | -1.79 | SELL |
| EMA (10) | 72.09 | SELL |
| SMA (10) | 71.99 | SELL |
| EMA (20) | 72.37 | SELL |
| SMA (20) | 72.61 | SELL |
| EMA (30) | 72.35 | SELL |
| SMA (30) | 72.78 | SELL |
| EMA (50) | 71.72 | BUY |
| SMA (50) | 72.52 | SELL |
| EMA (100) | 69.33 | BUY |
| SMA (100) | 69.12 | BUY |
| EMA (200) | 65.04 | BUY |
| SMA (200) | 64.22 | BUY |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.